From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

CVS Caremark Rx blasted the findings for cherry picking certain drugs in an effort to push what it called an 'anti-PBM' ...

(Reuters) - Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Three major drug middlemen needlessly marked up generic drugs for cancer, HIV, and multiple sclerosis to generate $7.3 ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

This was the stock's second consecutive day of gains.

If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans ...

Over the last 3 months, EPS estimates have seen 1 upward revision and 21 downward. Revenue estimates have seen 13 upward ...

UnitedHealth Group Inc. is set to report financial results Thursday, the first time its executives will speak publicly since ...

We recently published a list of 12 Best Safe Dividend Stocks for 2025. In this article, we are going to take a look at where ...